We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Our shares are listed on the SIX Swiss Exchange (NWRN).
June 19-20, 2019 - The St. Regis New York, New York City, USA
June 4-7, 2019 - Grand Hyatt, New York City, USA
May 7, 2019 - Congress Center, Basel, Switzerland